These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9696434)

  • 1. Magnesium in dialysis patients: serum levels and clinical implications.
    Navarro-González JF
    Clin Nephrol; 1998 Jun; 49(6):373-8. PubMed ID: 9696434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis.
    Navarro-González JF; Mora-Fernández C; García-Pérez J
    Semin Dial; 2009; 22(1):37-44. PubMed ID: 19250445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily magnesium intake and hypermagnesemia in hemodialysis patients with chronic kidney disease.
    Wyskida K; Witkowicz J; Chudek J; Więcek A
    J Ren Nutr; 2012 Jan; 22(1):19-26. PubMed ID: 21620724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium and Dialysis: The Neglected Cation.
    Alhosaini M; Leehey DJ
    Am J Kidney Dis; 2015 Sep; 66(3):523-31. PubMed ID: 25864370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal failure and magnesium metabolism.
    Lindeman RD
    Magnesium; 1986; 5(5-6):293-300. PubMed ID: 3807422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomagnesemia and hypermagnesemia.
    Massry SG; Seelig MS
    Clin Nephrol; 1977 Apr; 7(4):147-53. PubMed ID: 858210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients.
    Gonella M; Ballanti P; Della Rocca C; Calabrese G; Pratesi G; Vagelli G; Mazzotta A; Bonucci E
    Miner Electrolyte Metab; 1988; 14(4):240-5. PubMed ID: 3211092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between residual renal function, protein catabolic rate, and phosphate and magnesium levels in peritoneal dialysis patients.
    Pagé DE; Knoll GA; Cheung V
    Adv Perit Dial; 2002; 18():189-91. PubMed ID: 12402616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of decreasing dialysate magnesium in patients with chronic renal failure.
    Burnell JM; Teubner E
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():191-8. PubMed ID: 1029885
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
    Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
    Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
    Pagé D; Knoll G
    Adv Perit Dial; 2005; 21():185-7. PubMed ID: 16686315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypermagnesemia in hemodialysis due to excessive concentration of the element in the dialysate].
    Switlik I; Dziewanowski K
    Wiad Lek; 1990 Mar 1-15; 43(5-6):227-31. PubMed ID: 2195778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of magnesium binders in chronic kidney disease.
    Spiegel DM
    Semin Dial; 2007; 20(4):333-6. PubMed ID: 17635824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritoneal dialysis in the aged].
    Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
    Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium exposure and removal in chronic hemodialysis patients.
    Sigrist M; McIntyre CW
    J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.